| Authors: |
Ri M; Department of Hematology and Oncology, Nagoya City University Hospital, Nagoya, Japan., Suzuki K; Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan., Ishida T; Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan., Kuroda J; Division of Hematology and Oncology, Kyoto Prefectural University of Medicine, Kyoto, Japan., Tsukamoto T; Division of Hematology and Oncology, Kyoto Prefectural University of Medicine, Kyoto, Japan., Teshima T; Department of Hematology, Hokkaido University Hospital, Sapporo, Japan., Goto H; Department of Hematology, Hokkaido University Hospital, Sapporo, Japan., Jackson CC; Janssen Research & Development, LLC; Bridgewater, New Jersey, USA., Sun H; Janssen Research & Development, LLC; Bridgewater, New Jersey, USA., Pacaud L; Legend Biotech, Piscataway, New Jersey, USA., Fujikawa E; Janssen Pharmaceutical KK, Tokyo, Japan., Yeh TM; Janssen Research & Development, LLC; Bridgewater, New Jersey, USA., Hatayama T; Janssen Pharmaceutical KK, Tokyo, Japan., Aida K; Janssen Pharmaceutical KK, Tokyo, Japan., Sunagawa Y; Janssen Pharmaceutical KK, Tokyo, Japan., Iida S; Department of Hematology and Oncology, Nagoya City University Hospital, Nagoya, Japan. |
Accede al texto completo